AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
NovaBridge Biosciences
Video analysis: NBP
All videosNo video analysis for this stock yet. Request one from our team.
News: NBP
NovaBridge Appoints Martin Dewhurst to Board of Directors as an Independent Director
ROCKVILLE, Md., Sept. 08, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a global biotechnology company that identifies differentiated innovation and applies disciplined development, financing, and partnering strategies to create value, today announced the appointment of Martin Dewhurst to its Board of Directors (the “Board”) as an independent director, and as a member of both the Audit Committee and the Compensation Committee, effective immediately.
NovaBridge Biosciences to Participate in September Investor Conferences
ROCKVILLE, Md., Aug. 27, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a global biotechnology company that identifies differentiated innovation and applies disciplined development, financing, and partnering strategies to create value, today announced that the Company's leadership will participate in the following investor conferences in September 2026: Conference details: Cantor 2026 Global Healthcare Conference Format: Fireside Chat and one-on-one meetingsPresenter: Srishti Gupta, MD, MPP, Chief Executive Officer, NovaBridge BiosciencesDate: Thursday, September 10, 2026Time: 1:00 PM ETWebcast Link: Here H.C.
NovaBridge Biosciences (NBP) Q2 2026 Earnings Call Transcript
NovaBridge Biosciences (NBP) Q2 2026 Earnings Call Transcript
NovaBridge Reports First Half 2026 Financial Results and Highlights Pipeline Momentum and Strategic Execution
ROCKVILLE, Md., Aug. 20, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a global biotechnology company that identifies differentiated innovation and applies disciplined development, financing, and partnering strategies to create value, today reported financial results for the six months ended June 30, 2026, and provided a business update. During the first half of 2026, the Company continued executing its strategic priorities by progressing key clinical milestones for its lead programs. The Company also strengthened leadership, governance, and capital allocation to support long-term value creation.
NovaBridge to Report First Half 2026 Financial Results and Provide a Corporate Update on Thursday, August 20, 2026
ROCKVILLE, Md., Aug. 13, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a global biotechnology company that identifies differentiated innovation and applies disciplined development, financing, and partnering strategies to create value, today announced that it will hold a webcast on Thursday, August 20, 2026 at 9:00 AM ET/9:00 PM China Standard Time to discuss recent corporate progress and financial results for the first half ended June 30, 2026.
Woodside Energy Second Quarter Report for Period Ended 30 June 2026
Woodside Energy Group (ASX: WDS) (NYSE: WDS):2026 full-year guidancePriorCurrentTotal production volumes3MMboe172-186174-185Gas hub exposure4%~30No changeCapita
NovaBridge Biosciences to Hold Annual General Meeting on September 8, 2026
ROCKVILLE, Md., July 24, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative medicines for areas of significant unmet need, today announced that it will hold its annual general meeting of shareholders (the “AGM”) at NovaBridge Biosciences Shanghai office, 38F, AIA Tower, No. 866 Dongchangzhi Road, Shanghai, China on September 8, 2026 at 10:00 a.m. (Shanghai time).
I-Mab (NASDAQ:NBP) Trading Down 4.9% – Time to Sell?
Shares of I-Mab (NASDAQ: NBP - Get Free Report) dropped 4.9% during mid-day trading on Wednesday. The company traded as low as $1.7150 and last traded at $1.74. Approximately 354,237 shares were traded during mid-day trading, a decline of 50% from the average session volume of 705,434 shares. The stock had previously closed at $1.83.
